Compare Hims and Hers Health Inc (HIMS) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs uniQure N.V. Ordinary Shares — how do they compare? Hims and Hers Health Inc trades at $27.29 (market cap $6.47B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.45B). The key difference: Hims and Hers Health Inc is far larger — about 4.5× uniQure N.V. Ordinary Shares's market cap, and Hims and Hers Health Inc is more actively traded (10,989,212 versus 3,323,243). Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| HIMS | QURE | |
|---|---|---|
Market Cap | $6.47B | $1.45B |
Volume | 10,989,212 | 3,323,243 |
Sector | Health | Health |
52-Week High | $62.76 | $70.59 |
52-Week Low | $14.52 | $9.03 |
Typical Hold Time | 21 Days | 0 Days |
Enterprise Value | $7.17B | $707.46M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HIMS trades at $29.71, down 3.04% today, amid ongoing securities class action lawsuits. The stock shows bullish technical signals with strong moving average support and key resistance at $32. Fundamentally, while revenue grew to $2.35B in 2025, the company posted a net loss of -$142M in 2026 with negative profit margins, though it maintains a solid gross margin of 68.4%.
The investment outlook is mixed: technical indicators suggest near-term upside potential toward the $32.17 consensus target, but fundamental weakness and legal overhangs pose significant risks. Analyst sentiment leans cautious with 65% hold ratings, reflecting concerns about profitability and regulatory challenges despite growth prospects.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
